Our Clinical Publications

MR-Guided adaptive radiotherapy (SMART)

Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomes

Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer:

First Reported Clinical Outcomes From the UK

Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer

Protocol summary of the Emerald- Pancreas phase 1/expansion study located at Oxford University Hospital, UK

Stereotactic Magnetic Resonance−Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer

Acute and Late Patient-Reported Toxicity Outcomes

Phase 3 trial of SABR in localised prostate cancer

(PACE B)